Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
89.81 CHF | -0.63% | -3.71% | +5.82% |
Dec. 06 | Swiss Market Index Ends Week Little Changed; Holcim Shares Down | MT |
Dec. 06 | Novartis Reports 'Positive' Results From Phase 3 Study of Potential Blood Disorder Therapy | MT |
P/E ratio | Price to Book | PEG | EV / Sales | EV / EBITDA | EV / EBIT | Yield (Y) | Capi. ($) | ||
---|---|---|---|---|---|---|---|---|---|
18.64x | 4.571 | -0.8x | 4.32x | 10.99x | 11.49x | +3.68% | 205B | ||
65.04x | 43.35 | 0.55x | 16.77x | 47.47x | 52.66x | +0.63% | 744B | ||
34.76x | 24.48 | 1.63x | 12.18x | 24.59x | 27.4x | +1.44% | 493B | ||
21.77x | 4.964 | -0.44x | 4.18x | 12.19x | 13.76x | +3.27% | 359B | ||
37.07x | 36.86 | 0.5x | 6.59x | 14.28x | 14.8x | +3.54% | 311B | ||
14.45x | 5.554 | 0x | 4.43x | 10.49x | 11.94x | +2.96% | 261B | ||
15.5x | 5.686 | 0.98x | 3.66x | 9.55x | 10.66x | +3.83% | 235B | ||
25.01x | 5.071 | 0.59x | 4.39x | 13.67x | 13.7x | +2.29% | 211B | ||
30.17x | 21.56 | -1.09x | 5.88x | 10.23x | 13.19x | +3.33% | 147B | ||
15.61x | 1.647 | 0.05x | 3.24x | 8.24x | 9.93x | +6.54% | 146B | ||
17x | 1.511 | 0.66x | 2.64x | 9.02x | 9.69x | +4.19% | 122B | ||
-18.48x | 6.975 | 0.1x | 3.33x | 28.98x | 33.7x | +4.02% | 120B | ||
997.08x | 5.984 | -10.18x | 4.68x | 12.37x | 16.06x | +3.33% | 115B | ||
28.75x | 5.943 | 1.57x | 8.85x | 17.92x | 19.36x | +1.32% | 73.86B | ||
14.95x | 3.722 | -0.57x | 2.2x | 6.72x | 7.63x | +4.49% | 69.91B | ||
39.25x | 5.297 | 2.82x | 4.39x | 24.22x | 31.36x | +1.32% | 58.82B | ||
56.32x | 0.9065 | -2.75x | 2.4x | 10x | 34.9x | +4.75% | 43.59B | ||
52.22x | 6.992 | 1.32x | 10.76x | 41.99x | 44.99x | +0.48% | 43.32B | ||
22.67x | 2.014 | 0.49x | 3.72x | 14.85x | 16.48x | +1.66% | 43.28B | ||
Average | 78.30x | 10.16 | -0.24x | 5.72x | 17.25x | 20.72x | +3.00% | 200.09B | |
Weighted average by Cap. | 61.45x | 18.13 | 0.10x | 7.96x | 21.36x | 24.09x | +2.62% |
- Stock Market
- Equities
- NOVN Stock
- Sector Novartis AG
- Sector valuations